Now, it's an interesting mechanism that this bill uses. I haven't had the privilege of being on the Health Committee, but I've been looking at the bill, and it's a very short bill. What it is, is it's an interim solution, as we've heard. We're really waiting for this Therapeutic Products Bill, but, in the meantime, what this very simple bill does is it uses a deeming provision to make a standard under the Fair Trading Act. It's useful to have a look at that Fair Trading Act, because while it doesn't insert a provision into the Fair Trading Act, it says that there is to be a product safety standard as if it was made under section 29 of the Fair Trading Act. The purpose of the Fair Trading Act, in section 1A, "is to contribute to a trading environment in which the interests of consumers are protected;", some other things, and "(2) To this end, the Act— … (c) provides for the disclosure of consumer information relating to the supply of goods and services; and (d) promotes safety in respect of goods and services." So I can see why Todd Muller chose this Act as a vehicle to do what he's trying to do, and that we all agree in the House today to make that voluntary standard a mandatory one.